Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
<p>Multiplex immunohistochemical staining protocols.</p>
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | , , , , , , , , , , , , , , , , , , , |
| 出版: |
2025
|
| 主題: | |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
| _version_ | 1849927633649795072 |
|---|---|
| author | Hansol Lee (15054787) |
| author2 | Angela L. Ferguson (15050051) Camelia Quek (15049218) Ismael A. Vergara (15054784) Ines Pires daSilva (15056800) Ruth Allen (15056803) Tuba Nur Gide (15056806) Jordan W. Conway (15056809) Lambros T. Koufariotis (15056812) Nicholas K. Hayward (14956488) Nicola Waddell (12694196) Matteo S. Carlino (15056815) Alexander M. Menzies (11420816) Robyn P.M. Saw (15056818) Elena Shklovskaya (15056821) Helen Rizos (15008946) Serigne Lo (15056824) Richard A. Scolyer (10778711) Georgina V. Long (11420813) Umaimainthan Palendira (15050084) James S. Wilmott (15008931) |
| author2_role | author author author author author author author author author author author author author author author author author author author author |
| author_facet | Hansol Lee (15054787) Angela L. Ferguson (15050051) Camelia Quek (15049218) Ismael A. Vergara (15054784) Ines Pires daSilva (15056800) Ruth Allen (15056803) Tuba Nur Gide (15056806) Jordan W. Conway (15056809) Lambros T. Koufariotis (15056812) Nicholas K. Hayward (14956488) Nicola Waddell (12694196) Matteo S. Carlino (15056815) Alexander M. Menzies (11420816) Robyn P.M. Saw (15056818) Elena Shklovskaya (15056821) Helen Rizos (15008946) Serigne Lo (15056824) Richard A. Scolyer (10778711) Georgina V. Long (11420813) Umaimainthan Palendira (15050084) James S. Wilmott (15008931) |
| author_role | author |
| dc.creator.none.fl_str_mv | Hansol Lee (15054787) Angela L. Ferguson (15050051) Camelia Quek (15049218) Ismael A. Vergara (15054784) Ines Pires daSilva (15056800) Ruth Allen (15056803) Tuba Nur Gide (15056806) Jordan W. Conway (15056809) Lambros T. Koufariotis (15056812) Nicholas K. Hayward (14956488) Nicola Waddell (12694196) Matteo S. Carlino (15056815) Alexander M. Menzies (11420816) Robyn P.M. Saw (15056818) Elena Shklovskaya (15056821) Helen Rizos (15008946) Serigne Lo (15056824) Richard A. Scolyer (10778711) Georgina V. Long (11420813) Umaimainthan Palendira (15050084) James S. Wilmott (15008931) |
| dc.date.none.fl_str_mv | 2025-11-25T13:03:34Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30707059 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Supplementary_Table_S2_from_Intratumoral_CD16_sup_sup_Macrophages_Are_Associated_with_Clinical_Outcomes_of_Patients_with_Metastatic_Melanoma_Treated_with_Combination_Anti-PD-1_and_Anti-CTLA-4_Therapy/30707059 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers Prognostic biomarkers Immunology Immune responses to cancer Innate immunity Tumor-associated macrophages Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |
| dc.title.none.fl_str_mv | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Multiplex immunohistochemical staining protocols.</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_845bda78177032d27e0eda02e1317d2b |
| identifier_str_mv | 10.1158/1078-0432.30707059 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30707059 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 TherapyHansol Lee (15054787)Angela L. Ferguson (15050051)Camelia Quek (15049218)Ismael A. Vergara (15054784)Ines Pires daSilva (15056800)Ruth Allen (15056803)Tuba Nur Gide (15056806)Jordan W. Conway (15056809)Lambros T. Koufariotis (15056812)Nicholas K. Hayward (14956488)Nicola Waddell (12694196)Matteo S. Carlino (15056815)Alexander M. Menzies (11420816)Robyn P.M. Saw (15056818)Elena Shklovskaya (15056821)Helen Rizos (15008946)Serigne Lo (15056824)Richard A. Scolyer (10778711)Georgina V. Long (11420813)Umaimainthan Palendira (15050084)James S. Wilmott (15008931)CancerCancer Detection and DiagnosisImmuno-oncologyBiomarkersPrognostic biomarkersImmunologyImmune responses to cancerInnate immunityTumor-associated macrophagesImmunotherapyBiomarkers for immunotherapyCheckpoint blockadeCombination immunotherapySkin CancersMelanoma<p>Multiplex immunohistochemical staining protocols.</p>2025-11-25T13:03:34ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30707059https://figshare.com/articles/dataset/Supplementary_Table_S2_from_Intratumoral_CD16_sup_sup_Macrophages_Are_Associated_with_Clinical_Outcomes_of_Patients_with_Metastatic_Melanoma_Treated_with_Combination_Anti-PD-1_and_Anti-CTLA-4_Therapy/30707059CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307070592025-11-25T13:03:34Z |
| spellingShingle | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy Hansol Lee (15054787) Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers Prognostic biomarkers Immunology Immune responses to cancer Innate immunity Tumor-associated macrophages Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |
| status_str | publishedVersion |
| title | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_full | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_fullStr | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_full_unstemmed | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_short | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| title_sort | Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy |
| topic | Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers Prognostic biomarkers Immunology Immune responses to cancer Innate immunity Tumor-associated macrophages Immunotherapy Biomarkers for immunotherapy Checkpoint blockade Combination immunotherapy Skin Cancers Melanoma |